Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Kindred Biosciences, Inc. (KIN)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13
   10-K10-K10-K10-K10-K10-K10-K10-K
Net income  -21.8-61.4-49.7-30.9-22.5-27.1-27.1-4.2
Depreciation and amortization   [+]4.72.50.80.50.20.10.10.0
Asset impairment charges  3.8       
Stock-based compensation  7.67.46.35.23.64.24.40.9
Change in working capital   [+]-4.5-4.7-2.33.19.311.812.01.7
Other operating activities  0.4-0.2-0.20.2-9.3-11.7-11.3 
Cash from operations  -9.9-56.3-45.0-21.9-18.8-22.8-21.9-1.6
   
Capital expenditures   [+]-3.6-8.4-13.9-5.9-1.0-0.7-0.40.0
Purchases of short-term investments, net  9.3-39.430.33.36.330.2-88.2 
Cash from investing  5.8-47.816.6-2.75.329.4-88.60.0
   
Issuance of common stock, net  0.243.149.252.2  58.154.9
Option exercises  0.42.01.00.50.20.30.10.0
Other cash from financing  0.022.71.71.00.30.70.211.1
Cash from financing  -0.363.849.952.70.20.358.266.0
   
Free cash flow  -13.5-64.8-59.0-27.8-19.7-23.5-22.4-1.6
        Per share (diluted)  ($0.34)($1.68)($1.90)($1.11)($0.99)($1.19)($1.19)($0.43)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy